Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
Netherlands

LSP (EQT Life Sciences)

Investment focus

Sectors

Biotech
Healthtech

Investment stages

Seed
Series A
Series B
Growth

Geographic focus

Europe
United States
Global

Investment thesis

Amsterdam-based European life sciences VC with 35+ year track record and €3.5B raised across 12 funds. Part of EQT Group since 2022. Backs innovative healthcare companies from seed to late stage across Europe and US.

Typical check size

€5M – €75M

Fund size: €1B (LSP 7, 2022)

Browse similar check sizes →

Portfolio highlights

argenx - Belgian immunology biotech (major success, Euronext/Nasdaq listed)
Crucell - vaccine company (acquired by Johnson & Johnson)
Neuravi - neurovascular device company (acquired by J&J)

Contact

www.lspvc.com
Netherlands

Research with AI

Learn more about LSP (EQT Life Sciences) using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what LSP (EQT Life Sciences) and similar investors look for:

Biotech pitch guideHealthtech pitch guide

More investors in Netherlands

4impactEIT Climate-KICEIT InnoEnergyEndeit CapitalView all in Netherlands

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideGrowth fundraising guide
Fundraising in Netherlands

Tips, programs, and cultural notes

More Biotech investors

AbingworthACF InvestorsAhren Innovation CapitalAlmi Invest GreenTechView all Biotech investors